​Rigshospitalet and Medtronic have launched a new long-term strategic partnership. The aim of the partnership is to develop and test new approaches to specialised care and capacity management with the ambition of improving patient outcomes, supporting healthcare professionals and making better use of resources across the healthcare system.

​The Phase 1 Unit at Rigshospitalet participated in Danish Cancer Research Days 2026 in Odense, bringing together researchers and healthcare professionals from across Denmark to share the latest developments in cancer care and research.

​The first Nordic AI conference for university hospitals provided a forum for sharing experiences, with the aim of strengthening collaboration on AI for the benefit of patients and healthcare systems.

​​Rigshospitalet, Charité – Universitätsmedizin Berlin and Berlin Institute of Health at Charité have entered into an ambitious partnership aimed at strengthening innovation, emergency preparedness and more.

​We are delighted to congratulate our medical student, Sediga Nateqi, on the successful completion of her master’s thesis “The Potential of Antibody-Drug Conjugates in Biliary Tract Cancer” at the Phase 1 Unit, Rigshospitalet.

​Whole genome sequencing reveals additional insights and opportunities for precision treatment in brain tumour patients.

​Differences in Tumour Mutational Burden Assessment – Results from a National Ring Trial​

A new collaboration between Rigshospitalet, Zealand University Hospital and Siemens Healthineers aims to strengthen quality of care and health equity by bringing together public and private actors to develop solutions that work in practice.

Leaders and experts from the Nordic University Hospital Alliance (NUHA), representing the university hospitals of Oslo, Copenhagen, Stockholm, Helsinki and Reykjavík, gathered in Oslo on 4–5 May 2026 for the NUHA Annual Summit.